APA (7th ed.) Citation

Hu, C., Tompson, D., Magee, M., Chen, Q., Liu, Y. M., Zhu, W., . . . Liu, Y. (2015). Single and Multiple Dose Pharmacokinetics, Pharmacodynamics and Safety of the Novel Lipoprotein-Associated Phospholipase A2 Enzyme Inhibitor Darapladib in Healthy Chinese Subjects: An Open Label Phase-1 Clinical Trial. PloS one, 10(10), e0139862. https://doi.org/10.1371/journal.pone.0139862

Chicago Style (17th ed.) Citation

Hu, Chaoying, Debra Tompson, Mindy Magee, Qian Chen, Yan Mei Liu, Wenjing Zhu, Hongxin Zhao, Annette S. Gross, and Yun Liu. "Single and Multiple Dose Pharmacokinetics, Pharmacodynamics and Safety of the Novel Lipoprotein-Associated Phospholipase A2 Enzyme Inhibitor Darapladib in Healthy Chinese Subjects: An Open Label Phase-1 Clinical Trial." PloS One 10, no. 10 (2015): e0139862. https://doi.org/10.1371/journal.pone.0139862.

MLA (9th ed.) Citation

Hu, Chaoying, et al. "Single and Multiple Dose Pharmacokinetics, Pharmacodynamics and Safety of the Novel Lipoprotein-Associated Phospholipase A2 Enzyme Inhibitor Darapladib in Healthy Chinese Subjects: An Open Label Phase-1 Clinical Trial." PloS One, vol. 10, no. 10, 2015, p. e0139862, https://doi.org/10.1371/journal.pone.0139862.